HomeCompareQTNT vs FCPT

QTNT vs FCPT: Dividend Comparison 2026

QTNT yields 526.32% · FCPT yields 6.05%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 QTNT wins by $297.7K in total portfolio value
10 years
QTNT
QTNT
● Live price
526.32%
Share price
$0.38
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$346.8K
Annual income
$903.77
Full QTNT calculator →
FCPT
FCPT
● Live price
6.05%
Share price
$23.65
Annual div
$1.43
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.1K
Annual income
$5,775.28
Full FCPT calculator →

Portfolio growth — QTNT vs FCPT

📍 QTNT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodQTNTFCPT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, QTNT + FCPT cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
QTNT pays
FCPT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

QTNT
Annual income on $10K today (after 15% tax)
$44,736.84/yr
After 10yr DRIP, annual income (after tax)
$768.20/yr
FCPT
Annual income on $10K today (after 15% tax)
$514.49/yr
After 10yr DRIP, annual income (after tax)
$4,908.99/yr
At 15% tax rate, FCPT beats the other by $4,140.78/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of QTNT + FCPT for your $10,000?

QTNT: 50%FCPT: 50%
100% FCPT50/50100% QTNT
Portfolio after 10yr
$197.9K
Annual income
$3,339.53/yr
Blended yield
1.69%
📊

Analyst Conviction Gap

Where Wall Street is split right now

QTNT
Analyst Ratings
5
Buy
2
Hold
Consensus: Buy
Price Target
$1.50
+294.7% upside vs current
Range: $1.50 — $1.50
FCPT
Analyst Ratings
5
Buy
10
Hold
Consensus: Hold
Price Target
$27.00
+14.2% upside vs current
Range: $25.00 — $29.00
Altman Z
1.4
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

QTNT buys
0
FCPT buys
0
No recent congressional trades found for QTNT or FCPT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricQTNTFCPT
Forward yield526.32%6.05%
Annual dividend / share$2.00$1.43
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%15.8%
Portfolio after 10y$346.8K$49.1K
Annual income after 10y$903.77$5,775.28
Total dividends collected$208.2K$24.1K
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusBuyHold
Analyst price target$1.50$27.00

Year-by-year: QTNT vs FCPT ($10,000, DRIP)

YearQTNT PortfolioQTNT Income/yrFCPT PortfolioFCPT Income/yrGap
1← crossover$37,016$26,315.79$11,401$700.92+$25.6KQTNT
2$85,126$45,518.68$13,064$864.84+$72.1KQTNT
3$140,000$48,915.77$15,051$1,072.48+$124.9KQTNT
4$187,393$37,592.70$17,442$1,337.22+$170.0KQTNT
5$224,024$23,513.34$20,340$1,677.08+$203.7KQTNT
6$252,841$13,135.34$23,880$2,116.57+$229.0KQTNT
7$277,467$6,927.57$28,241$2,689.36+$249.2KQTNT
8$300,442$3,552.48$33,660$3,442.07+$266.8KQTNT
9$323,271$1,797.49$40,456$4,439.95+$282.8KQTNT
10$346,803$903.77$49,063$5,775.28+$297.7KQTNT

QTNT vs FCPT: Complete Analysis 2026

QTNTStock

Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, commercializes, and sells products for the global transfusion diagnostics market in the United States, France, Japan, and internationally. The company is developing MosaiQ, a proprietary technology platform, which provides tests for immunohematology, serological disease screening, and molecular disease screening. Its conventional reagent products for blood grouping include antisera products that are used to identify blood group antigens; reagent red blood cells, which enable the identification of blood group antibodies; whole blood control products for use as daily quality assurance tests; and ancillary products that are used to support blood grouping. The company also offers MosaiQ SDS Microarray that is designed as a serological disease screening microarray comprised assays to detect cytomegalovirus and Syphilis; MosaiQ MDS Microarray that is designed as a molecular disease screening microarray test for donor red cells or source plasma; MosaiQ IH Microarray as a blood grouping microarray; MosaiQ Autoimmune Microarray; MosaiQ COVID-19; and MosaiQ IH3 Microarray. It sells its products to hospitals, donor collection agencies, independent testing laboratories, original equipment manufacturers, and blood banking operation and other diagnostics companies. Quotient Limited was founded in 2007 and is headquartered in Eysins, Switzerland.

Full QTNT Calculator →

FCPTREIT

FCPT, headquartered in Mill Valley, CA, is a real estate investment trust primarily engaged in the acquisition and leasing of restaurant properties. The Company seeks to grow its portfolio by acquiring additional real estate to lease, on a net basis, for use in the restaurant and retail industries.

Full FCPT Calculator →
📬

Get this QTNT vs FCPT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

QTNT vs SCHDQTNT vs JEPIQTNT vs OQTNT vs KOQTNT vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.